COGENT BIOSCIENCES INC (COGT) Stock Cash Flow
NASDAQ:COGT - Nasdaq - US19240Q2012 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -242.30M | -192.41M | -140.24M | -72.27M | -74.81M | |||
| Depreciation Amortization | 2.42M | 2.27M | 840.00K | 150.00K | 720.00K | |||
| Change In Working Capital | 17.67M | 11.44M | 750.00K | 2.02M | -5.32M | |||
| Other non cash items | 30.92M | 25.07M | 20.01M | 11.34M | 43.55M | |||
| OPERATING CASH FLOW | -191.29M | -153.62M | -118.64M | -58.76M | -35.85M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -814.00K | -2.80M | -6.86M | -1.72M | 0.00 | |||
| Other Investing Activity | -12.10M | -95.03M | -117.86M | 0.00 | 8.42M | |||
| INVESTING CASH FLOW | -12.91M | -97.82M | -124.72M | -1.72M | 8.42M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 214.42M | 163.54M | 163.56M | 38.06M | 232.20M | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | -90.00K | N/A | |||
| FINANCING CASH FLOW | 214.42M | 163.54M | 163.56M | 37.98M | 232.20M | |||
| CHANGE IN CASH | 10.22M | -87.91M | -79.80M | -22.50M | 204.77M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -191.29M | -153.62M | -118.64M | -58.76M | -35.85M | |||
| Capital Expenditure | -814.00K | -2.80M | -6.86M | -1.72M | 0.00 | |||
| FREE CASH FLOW | -192.10M | -156.42M | -125.50M | -60.48M | -35.85M | |||
All data in USD